{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:36:02Z","timestamp":1771511762917,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Precision medicine and artificial intelligence (AI) are increasingly integrated into colorectal cancer (CRC) care, offering personalised treatment strategies and data-driven decision support. While these technologies promise improved outcomes, they also raise challenges concerning clinical decision-making, the doctor-patient relationship, and ethics. This study explores physicians\u2019 perspectives on integrating precision medicine and AI in CRC care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A qualitative study was conducted using semi-structured interviews with ten CRC physicians from six European countries. Participants were recruited through purposive and snowball sampling. Interviews were analysed using thematic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three key themes emerged from the analysis. First, physicians described precision medicine as a logical extension of existing tailoring practices, offering new opportunities while introducing complexity. Many expressed concerns about the blurred boundary between experimental and standard treatments, noting potential implications for equity and ethical decision-making. Second, AI was viewed as a future partner in care, with the potential to enhance efficiency and assist in synthesising complex data. However, participants voiced concerns about trust, clinical responsibility, and the lack of regulatory clarity, particularly due to AI\u2019s \u201cblack box\u201d nature. Finally, doctors reported challenges in communicating both precision medicine and AI-based recommendations to patients. They emphasised the importance of adapting communication strategies to individual patients and highlighted the need for structured approaches to ensure patient understanding and prevent miscommunication, especially when dealing with uncertain outcomes or emerging technologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The findings highlight both the opportunities and challenges of integrating precision medicine and AI in CRC care. Addressing concerns related to communication, ethics, and regulation requires clear guidance and improved support for clinicians. Precision medicine and AI enhance CRC care but demand robust communication, regulation, and ethical safeguards to ensure transparency, trust, and physician autonomy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12911-025-03134-0","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:09:55Z","timestamp":1753884595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring doctors\u2019 perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship"],"prefix":"10.1186","volume":"25","author":[{"given":"Mirko","family":"Ancillotti","sequence":"first","affiliation":[]},{"given":"\u00c5sa","family":"Grauman","sequence":"additional","affiliation":[]},{"given":"Jorien","family":"Veldwijk","sequence":"additional","affiliation":[]},{"given":"\u00c5smund","family":"Flobak","sequence":"additional","affiliation":[]},{"given":"Deborah","family":"Mascalzoni","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"1","key":"3134_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-016-0183-8","volume":"9","author":"S McGrath","year":"2016","unstructured":"McGrath S, Ghersi D. Building towards precision medicine: empowering medical professionals for the next revolution. BMC Med Genom. 2016;9(1):23.","journal-title":"BMC Med Genom"},{"key":"3134_CR2","volume-title":"International agency for research on cancer. Colorectal cancer.Fact sheet","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. International agency for research on cancer. Colorectal cancer.Fact sheet. Lyon: GLOBOCAN; 2022."},{"issue":"4","key":"3134_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","volume":"72","author":"F Ciardiello","year":"2022","unstructured":"Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. Cancer J Clin. 2022;72(4):372\u2013401.","journal-title":"Cancer J Clin"},{"key":"3134_CR4","doi-asserted-by":"publisher","first-page":"175883592110727","DOI":"10.1177\/17588359211072703","volume":"14","author":"JE Riedesser","year":"2022","unstructured":"Riedesser JE, Ebert MP, Betge J. Precision medicine for metastatic colorectal cancer in clinical practice. Therapeutic Adv Med Oncol. 2022;14:17588359211072703.","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"1","key":"3134_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","volume":"7","author":"FA Zeineddine","year":"2023","unstructured":"Zeineddine FA, Zeineddine MA, Yousef A, Gu Y, Chowdhury S, Dasari A, et al. Survival improvement for patients with metastatic colorectal cancer over Twenty years. Npj Precision Oncol. 2023;7(1):16.","journal-title":"Npj Precision Oncol"},{"issue":"1","key":"3134_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12885-020-07090-y","volume":"20","author":"E Altunel","year":"2020","unstructured":"Altunel E, Roghani RS, Chen K-Y, Kim SY, McCall S, Ware KE, et al. Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer. BMC Cancer. 2020;20(1):592.","journal-title":"BMC Cancer"},{"key":"3134_CR7","doi-asserted-by":"crossref","unstructured":"Burri GP, Golivi Y, Luong T, Merchant N, Nagaraju GP. Chapter 5 - Approach of artificial intelligence in colorectal cancer and in precision medicine. In: Nagaraju GP, Amouda V, Dinakara Rao A, Editors. Computational methods in drug discovery and repurposing for cancer therapy. Academic. 2023:59\u201371.","DOI":"10.1016\/B978-0-443-15280-1.00016-9"},{"issue":"22","key":"3134_CR8","first-page":"3870","volume":"16","author":"PW Underwood","year":"2024","unstructured":"Underwood PW, Pawlik TM. Precision medicine for metastatic colorectal cancer. Where Do We Stand? Cancers. 2024;16(22):3870.","journal-title":"Where Do We Stand? Cancers"},{"key":"3134_CR9","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","volume":"86","author":"AM Tsimberidou","year":"2020","unstructured":"Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"3134_CR10","first-page":"3575","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, He X, Nie H, Zhou J, Cao P, Ou C. Application of artificial intelligence to the diagnosis and therapy of colorectal cancer. Am J Cancer Res. 2020;10(11):3575\u201398.","journal-title":"Am J Cancer Res"},{"key":"3134_CR11","doi-asserted-by":"publisher","first-page":"119686","DOI":"10.1016\/j.cca.2024.119686","volume":"559","author":"Z Xu","year":"2024","unstructured":"Xu Z, Li W, Dong X, Chen Y, Zhang D, Wang J, et al. Precision medicine in colorectal cancer: leveraging multi-omics, Spatial omics, and artificial intelligence. Clin Chim Acta. 2024;559:119686.","journal-title":"Clin Chim Acta"},{"key":"3134_CR12","doi-asserted-by":"crossref","unstructured":"Aikemu B, Xue P, Hong H, Jia H, Wang C, Li S et al. Artificial intelligence in decision-making for colorectal cancer treatment strategy: an observational study of implementing Watson for oncology in a 250-case cohort. Front Oncol. 2021;10.","DOI":"10.3389\/fonc.2020.594182"},{"issue":"9","key":"3134_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.trecan.2020.05.008","volume":"6","author":"C Luchini","year":"2020","unstructured":"Luchini C, Lawlor RT, Milella M, Scarpa A. Molecular tumor boards in clinical practice. Trends Cancer. 2020;6(9):738\u201344.","journal-title":"Trends Cancer"},{"issue":"1","key":"3134_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12911-023-02395-x","volume":"23","author":"\u00c5 Grauman","year":"2023","unstructured":"Grauman \u00c5, Ancillotti M, Veldwijk J, Mascalzoni D. Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis. BMC Med Inf Decis Mak. 2023;23(1):286.","journal-title":"BMC Med Inf Decis Mak"},{"key":"3134_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.breast.2019.10.001","volume":"49","author":"SM Carter","year":"2020","unstructured":"Carter SM, Rogers W, Win KT, Frazer H, Richards B, Houssami N. The ethical, legal and social implications of using artificial intelligence systems in breast cancer care. Breast. 2020;49:25\u201332.","journal-title":"Breast"},{"key":"3134_CR16","doi-asserted-by":"crossref","unstructured":"Triberti S, Durosini I, Pravettoni G. A third wheel effect in health decision making involving artificial entities: a psychological perspective. Front Public Health. 2020;8.","DOI":"10.3389\/fpubh.2020.00117"},{"issue":"1","key":"3134_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/13814788.2017.1375093","volume":"23","author":"A Moser","year":"2017","unstructured":"Moser A, Korstjens I, Series. Practical guidance to qualitative research. Part 1: introduction. Eur J Gen Pract. 2017;23(1):271\u20133.","journal-title":"Eur J Gen Pract"},{"key":"3134_CR18","doi-asserted-by":"crossref","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Administration and policy in mental health and mental health services research. 2015;42(5):533-44","DOI":"10.1007\/s10488-013-0528-y"},{"issue":"13","key":"3134_CR19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies:guided by information power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"issue":"2","key":"3134_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"key":"3134_CR21","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic analysis: a practical guide. 2021.","DOI":"10.1007\/978-3-319-69909-7_3470-2"},{"issue":"1","key":"3134_CR22","doi-asserted-by":"publisher","first-page":"160940691773384","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qualitative Methods. 2017;16(1):1609406917733847.","journal-title":"Int J Qualitative Methods"},{"key":"3134_CR23","doi-asserted-by":"publisher","first-page":"160940692096926","DOI":"10.1177\/1609406920969268","volume":"19","author":"AC Eldh","year":"2020","unstructured":"Eldh AC, \u00c5restedt L, Berter\u00f6 C. Quotations in qualitative studies: reflections on constituents, custom, and purpose. Int J Qualitative Methods. 2020;19:1609406920969268.","journal-title":"Int J Qualitative Methods"},{"key":"3134_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcancer.2021.08.002","volume":"84","author":"N Normanno","year":"2022","unstructured":"Normanno N, Apostolidis K, de Lorenzo F, Beer PA, Henderson R, Sullivan R, et al. Cancer biomarkers in the era of precision oncology: addressing the needs of patients and health systems. Sem Cancer Biol. 2022;84:293\u2013301.","journal-title":"Sem Cancer Biol"},{"issue":"4","key":"3134_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1021\/acsptsci.4c00008","volume":"7","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Maheshwari R, Bhattacharya S, Prajapati BG. Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies. ACS Pharmacol Translational Sci. 2024;7(4):967\u201390.","journal-title":"ACS Pharmacol Translational Sci"},{"issue":"5","key":"3134_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","volume":"25","author":"JK Sicklick","year":"2019","unstructured":"Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med. 2019;25(5):744\u201350.","journal-title":"Nat Med"},{"key":"3134_CR27","doi-asserted-by":"publisher","first-page":"100282","DOI":"10.1016\/j.jcpo.2021.100282","volume":"28","author":"M Lawler","year":"2021","unstructured":"Lawler M, Oliver K, Gijssels S, Aapro M, Abolina A, Albreht T, et al. The European code of cancer practice. J Cancer Policy. 2021;28:100282.","journal-title":"J Cancer Policy"},{"key":"3134_CR28","doi-asserted-by":"crossref","unstructured":"Arora K, Suehnholz SP, Zhang H, Ostrovnaya I, Kundra R, Nandakumar S et al. Genetic ancestry\u2013based differences in biomarker-based eligibility for precision oncology therapies. JAMA Oncol. 2025.","DOI":"10.1001\/jamaoncol.2024.5794"},{"issue":"3","key":"3134_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJM198707163170304","volume":"317","author":"B Freedman","year":"1987","unstructured":"Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141\u20135.","journal-title":"N Engl J Med"},{"issue":"5","key":"3134_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrclinonc.2017.8","volume":"14","author":"ED Saad","year":"2017","unstructured":"Saad ED, Paoletti X, Burzykowski T, Buyse M. Precision medicine needs randomized clinical trials. Nat Reviews Clin Oncol. 2017;14(5):317\u201323.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"3","key":"3134_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/curroncol28030149","volume":"28","author":"A Mitsala","year":"2021","unstructured":"Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial intelligence in colorectal cancer screening, diagnosis and treatment. A new era. Curr Oncol. 2021;28(3):1581\u2013607.","journal-title":"Curr Oncol"},{"issue":"1","key":"3134_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10676-022-09630-5","volume":"24","author":"PJ Nickel","year":"2022","unstructured":"Nickel PJ. Trust in medical artificial intelligence: a discretionary account. Ethics Inf Technol. 2022;24(1):7.","journal-title":"Ethics Inf Technol"},{"issue":"4","key":"3134_CR33","first-page":"2171","volume":"29","author":"T Pichler","year":"2021","unstructured":"Pichler T, Rohrmoser A, Letsch A, Westphalen CB, Keilholz U, Heinemann V, et al. Information, communication, and cancer patients\u2019 trust in the physician: what challenges do we have to face in an era of precision cancer medicine? Support Care Cancer. 2021;29(4):2171\u20138.","journal-title":"Support Care Cancer"},{"key":"3134_CR34","doi-asserted-by":"crossref","unstructured":"Shearer E, Cho M, Magnus D. Chapter 23 - Regulatory, social, ethical, and legal issues of artificial intelligence in medicine. In: Xing L, Giger ML, Min JK, editors. Artificial intelligence in medicine. Academic. 2021:457\u201377.","DOI":"10.1016\/B978-0-12-821259-2.00023-5"},{"issue":"1","key":"3134_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41591-018-0272-7","volume":"25","author":"WN Price","year":"2019","unstructured":"Price WN, Cohen IG. Privacy in the age of medical big data. Nat Med. 2019;25(1):37\u201343.","journal-title":"Nat Med"},{"issue":"4","key":"3134_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jamia\/ocz229","volume":"27","author":"WK Diprose","year":"2020","unstructured":"Diprose WK, Buist N, Hua N, Thurier Q, Shand G, Robinson R. Physician understanding, explainability, and trust in a hypothetical machine learning risk calculator. J Am Med Inf Assoc. 2020;27(4):592\u2013600.","journal-title":"J Am Med Inf Assoc"},{"issue":"8","key":"3134_CR37","first-page":"1691","volume":"21","author":"KA Kaphingst","year":"2019","unstructured":"Kaphingst KA, Peterson E, Zhao J, Gaysynsky A, Elrick A, Hong SJ, et al. Cancer communication research in the era of genomics and precision medicine: a scoping review. Genet Sci. 2019;21(8):1691\u20138.","journal-title":"Genet Sci"},{"issue":"1","key":"3134_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2017-315333","volume":"67","author":"M Lawler","year":"2018","unstructured":"Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, et al. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut. 2018;67(1):179.","journal-title":"Gut"},{"key":"3134_CR39","doi-asserted-by":"crossref","unstructured":"Zhou Y, Shi Y, Lu W, Wan F. Did artificial intelligence invade humans? The study on the mechanism of patients\u2019 willingness to accept artificial intelligence medical care: from the perspective of intergroup threat theory. Front Psychol. 2022;13.","DOI":"10.3389\/fpsyg.2022.866124"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03134-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03134-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03134-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:50:05Z","timestamp":1757317805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03134-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3134"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03134-0","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants received written and oral information and provided oral informed consent to participate. The study and consent procedures were approved by the Swedish Ethical Review Authority (Dnr 2022-05307-01). All procedures were performed in accordance with the ethical standards of the national research committee and with the 1964 Declaration of Helsinki and its later amendments. Transcripts were anonymised to protect the participants\u2019 confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}